Skip to Content

Arix Bioscience PLC ARIX

Rating as of

Morningstar’s Analysis

Valuation
Currency in GBX
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance and develop healthcare and life science businesses that deliver or seek to deliver innovative therapies to patients. Its segment includes sourcing, financing and developing healthcare and life science businesses globally. The company's revenue is derived from the United Kingdom.

Contact
20 Berkeley Square
London, W1J 6EQ, United Kingdom
T +44 2072901050
Sector Healthcare
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 730